US Bancorp’s Calumet Specialty Products CLMT Stock Holding History

US Bancorp’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-350	Closed	-$1K	–	3553
2016 Q4	$1K	Sell	350 -700	-67%	-$2.86K	﹤0.01%	3435
2016 Q3	$5K	Hold	1,050	–	–	﹤0.01%	3154
2016 Q2	$5K	Sell	1,050 -1,650	-61%	-$9.35K	﹤0.01%	3169
2016 Q1	$32K	Hold	2,700	–	–	﹤0.01%	2577
2015 Q4	$54K	Hold	2,700	–	–	﹤0.01%	2407
2015 Q3	$66K	Hold	2,700	–	–	﹤0.01%	2313
2015 Q2	$69K	Sell	2,700 -1,000	-27%	-$26.5K	﹤0.01%	2356
2015 Q1	$89K	Hold	3,700	–	–	﹤0.01%	2232
2014 Q4	$83K	Buy	3,700 +700	+23%	+$18.2K	﹤0.01%	2258
2014 Q3	$82K	Buy	3,000 +1,000	+50%	+$30.2K	﹤0.01%	2222
2014 Q2	$64K	Buy	2,000 +1,000	+100%	+$29.8K	﹤0.01%	2365
2014 Q1	$26K	Hold	1,000	–	–	﹤0.01%	2735
2013 Q4	$26K	Sell	1,000 -1,300	-57%	-$36.3K	﹤0.01%	2672
2013 Q3	$63K	Sell	2,300 -5,300	-70%	-$166K	﹤0.01%	2241
2013 Q2	$276K	Buy	+7,600	New	+$273K	﹤0.01%	1474

Other funds holding CLMT

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SPCM

Sound Point Capital Management New York $28.3M AUM 13.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's CLMT Position: Q1 2017 in Review

US Bancorp sold out of Calumet Specialty Products (CLMT) in Q1 2017, closing a stake of 350 shares — an estimated $1K sold.

US Bancorp first reported a position in CLMT in Q2 2013 and held it in 15 quarters. The position peaked at $276K in Q2 2013. 68 funds tracked by Wall St. Rank hold CLMT as of Q1 2017.

US Bancorp reported no remaining Calumet Specialty Products position as of Q1 2017 after selling out during the quarter.
US Bancorp sold 350 Calumet Specialty Products shares in Q1 2017, an estimated $1K.
US Bancorp first reported a position in Calumet Specialty Products in Q2 2013 and held it in 15 quarters.
US Bancorp's Calumet Specialty Products position peaked at $276K in Q2 2013.
68 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2017.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.